Answer
The Orphan Drug Act, enacted in 1983, was significant due to Jack Klugman's advocacy. This legislation encouraged pharmaceutical companies to develop drugs for rare diseases by providing financial incentives and regulatory assistance. Klugman's efforts effectively addressed a critical gap in healthcare by ensuring that individuals with rare disorders had access to life-changing treatments.